Avantor, Inc. Interest Expense Nonoperating
Avantor, Inc. (AVTR) reported Interest Expense Nonoperating of $42.90 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-04-29
- Avantor, Inc. interest expense nonoperating for the quarter ending 2026-03-31 was $42.90M, a 1.66% increase year-over-year.
- Avantor, Inc. interest expense nonoperating for the quarter ending 2025-12-31 was $40.00M, a 10.91% decline year-over-year.
- Avantor, Inc. interest expense nonoperating for the quarter ending 2025-09-30 was $44.20M, a 9.24% decline year-over-year.
- Avantor, Inc. interest expense nonoperating for the quarter ending 2025-06-30 was $43.40M, a 28.74% decline year-over-year.
- Avantor, Inc. interest expense nonoperating for fiscal 2025 was $169.80M, a 22.39% decline from fiscal 2024.
- Avantor, Inc. interest expense nonoperating for fiscal 2024 was $218.80M, a 23.17% decline from fiscal 2023.
- Avantor, Inc. interest expense nonoperating for fiscal 2023 was $284.80M, a 7.15% increase from fiscal 2022.
- Avantor, Inc. interest expense nonoperating for fiscal 2022 was $265.80M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-03-31 | $42.90M 10-Q · filed 2026-04-29 | $82.90M derived: sum of 2 quarters · filed 2026-04-29 | $127.10M derived: sum of 3 quarters · filed 2026-04-29 | $170.50M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $40.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $84.20M derived: sum of 2 quarters · filed 2026-02-11 | $127.60M derived: sum of 3 quarters · filed 2026-02-11 | $169.80M 10-K · filed 2026-02-11 |
| 2025-09-30 | $44.20M 10-Q · filed 2025-10-29 | $87.60M derived: sum of 2 quarters · filed 2025-10-29 | $129.80M 10-Q · filed 2025-10-29 | $174.70M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $43.40M 10-Q · filed 2025-08-01 | $85.60M 10-Q · filed 2025-08-01 | $130.50M derived: sum of 3 quarters · filed 2026-04-29 | $179.20M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $42.20M 10-Q · filed 2026-04-29 | $87.10M derived: sum of 2 quarters · filed 2026-04-29 | $135.80M derived: sum of 3 quarters · filed 2026-04-29 | $196.70M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $44.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $93.60M derived: sum of 2 quarters · filed 2026-02-11 | $154.50M derived: sum of 3 quarters · filed 2026-02-11 | $218.80M 10-K · filed 2026-02-11 |
| 2024-09-30 | $48.70M 10-Q · filed 2025-10-29 | $109.60M derived: sum of 2 quarters · filed 2025-10-29 | $173.90M 10-Q · filed 2025-10-29 | |
| 2024-06-30 | $60.90M 10-Q · filed 2025-08-01 | $125.20M 10-Q · filed 2025-08-01 | ||
| 2024-03-31 | $64.30M 10-Q · filed 2025-04-25 | |||
| 2023-12-31 | $284.80M 10-K · filed 2026-02-11 | |||
| 2022-12-31 | $265.80M 10-K · filed 2025-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |